Alabama Clinical Trials

A listing of Alabama clinical trials actively recruiting patient volunteers.

Found in the southeastern United States, people love exploring Alabama for its 1,500 miles of inland waterways. Known as “The Heart of Dixie” and “The Cotton State,” the biggest cities include Montgomery, Birmingham, Auburn, and Mobile. Today, Alabama has a diverse economy and one of the most active college athletics scenes in the United States. The University of Alabama Crimson Tide is one of the “winningest” college athletic programs in the country, with football head coach Nick Saban a true local celebrity. UAB Hospitaland the regional Huntsville Hospital are the largest healthcare providers, with the latter serving northern Alabama.

Filter by Condition
1239 trials found

Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults

NCT04707963

This study will evaluate the adaptations in skeletal muscle that occur in response to 10 weeks of weight training with or without peanut protein supplementation in untrained men and women ages 18-30

Conditions: Sarcopenia
Phase: Not Applicable

Sustaining Aviator Performance During Extended Operational Flight

NCT04697901

Future aviation operations are anticipated to change as advances in technology enable automation of more tasks. Development of new platforms under the Future Vertical Lift program are also anticipated to change the nature of missions as they are being designed to cover further distances. Longer duration flights coupled with greater automated features are expected to shift the role of the aviator, resulting in an increased need for attention maintenance, which creates potential problems related t ...

Conditions: Transcranial Direct Current Stimulation
Phase: Not Applicable

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677543

The primary objective of this study is to generate evidence demonstrating the domain specification via modern psychometric methods, reliability, validity, and responsiveness of Quality of Life - Bronchiectasis (QoL-B) and Patient-Reported Outcome Measurement Information System - Fatigue-Short Form (PROMIS F-SF 7a) in participants with newly diagnosed nontuberculous mycobacterial (NTM) lung infection caused by Myobaxterium avium Complex (MAC).

Conditions: Mycobacterium Infections, Nontuberculous

Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677569

The main objective of this study is to evaluate the efficacy of ALIS (amikacin liposome inhalation suspension) + Azithromycin + Ethambutol compared to the ELC (empty liposome control) + Azithromycin + Ethambutol on participant reported respiratory symptoms at Month 13.

Conditions: Mycobacterium Infections, Nontuberculous

DreamKit Diagnostic Validation

NCT04671342

This study has been developed in order to demonstrate diagnostic efficacy of the DreamKit device against polysomnography.

Conditions: Sleep Apnea, Obstructive, Sleep Apnea, Central
Phase: Not Applicable

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm

NCT04671082

This is a double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of tolperisone (a non-opioid) or placebo administered in subjects with pain due to acute back muscle spasm.

Conditions: Back Muscle Spasm, Back Pain, Back Strain, Back Spasm Upper, Muscle Spasm, Acute Pain

Improving Access and Affordability of Adult Hearing Healthcare

NCT04671381

This project will address quality of care issues associated with hearing loss in adults who have mild-to-moderate hearing loss and who have no access to hearing healthcare. Through the use of three different interventions involving personal sound amplification products (PSAPs), it will lead to options that will increase access and affordability of hearing healthcare for adults with mild-to-moderate hearing loss.

Conditions: Hearing Loss
Phase: Not Applicable

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

NCT04655313

This is a Phase 2, open label, maximal usage PK and safety study of ARQ-151 cream 0.3% in pediatric subjects (ages 6 to 11 years old) with plaque psoriasis:

Conditions: Psoriasis, Plaque Psoriasis

Juice Plus Supplement Clinical Trial

NCT04656860

The study is designed to determine whether encapsulated fruit and vegetable juice concentrates can improve biological indicators of cognitive and multiple dimensions of memory and learning.

Conditions: Cognitive Impairment, Alzheimer Disease, Early Onset, Mild Cognitive Impairment
Phase: Not Applicable

Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery

NCT04654221

To evaluate the differences between serum cystatin C based estimated glomerular filtration rate (eGFRcys), serum creatinine based eGFR (eGFRcreat) and measured glomerular filtration rate (mGFR) in subjects at high risk for acute kidney injury (AKI) approximately 90 days following cardiac surgery

Conditions: Cardiac Surgery

Improving Thinking in Everyday Life After Covid-19

NCT04644172

The purpose of this initial study is to evaluate a new form of cognitive rehabilitation therapy for improving your ability to think, particularly how rapidly you process information that you receive from your senses, e.g., sight, hearing, and smell. The study will also test how often and how well you carry out tasks that rely on thinking in your daily life. You will be randomly assigned to receive the new therapy soon or about six months later. In other words, your treatment schedule will be det ...

Conditions: Covid-19, Cognitive Impairment
Phase: Phase 1/2

MIMICS-3D-USA Registry Study

NCT04640597

The MIMICS-3D-USA Study is a prospective, multicentre, observational study (non-investigational) of the BioMimics 3D Vascular Stent System that evaluates evaluate safety, effectiveness and device performance within a real-world clinical population of patients undergoing femoropopliteal intervention for the treatment of peripheral artery disease.

Conditions: Peripheral Arterial Disease